PVP-I
Showing 1 - 25 of >10,000
Virus Infection, RNA, Effect of Drug, Efficacy, Self Trial in Dhaka (0.6% PVP-I oral and nasal spray to moderately ill COVID-19
Completed
- Virus Infection, RNA
- +2 more
- 0.6% PVP-I oral and nasal spray to moderately ill COVID-19 positive patient
- +3 more
-
Dhaka, Dhanmondi, Bangladesh
- +3 more
Jan 19, 2022
COVID-19 Trial in Stanford (Povidone-Iodine 2%, Povidone-Iodine 0.5%, Isotonic saline 0.9%)
Completed
- COVID-19
- Povidone-Iodine 2%
- +2 more
-
Stanford, CaliforniaStanford Health Care
Oct 19, 2021
Covid19, SARS-CoV 2 Infection Trial in Taipei (Carrageenan nasal spray and 1% PVP- mouthwash and gargle)
Recruiting
- Covid19
- SARS-CoV 2 Infection
- Carrageenan nasal spray and 1% PVP- mouthwash and gargle
-
Taipei, TaiwanNational Taiwan University Hospital
Jun 27, 2022
2019 Novel Coronavirus Infection Trial in Shanghai (PVP-I Nasal Irrigation and gargling)
Recruiting
- 2019 Novel Coronavirus Infection
- PVP-I Nasal Irrigation and gargling
-
Shanghai, Shanghai, ChinaRuijin Hospital,Shanghai Jiaotong University school of medicine
May 17, 2022
COVID-19 Trial in Erzurum (Hypochlorous Acid 0.02% Soln,Top (Crystaline) (HClO))
Completed
- COVID-19
- Hypochlorous Acid 0.02% Soln,Top (Crystaline) (HClO)
-
Erzurum, TurkeyAtatürk University Faculty of Dentistry
Jan 28, 2022
SARS-CoV-2, COVID-19, Mouthwashes Trial in Jeddah (Distilled Water, 1% Povidone Iodine (PVP-I), 1.5% Hydrogen Peroxide (H2O2))
Completed
- SARS-CoV-2
- +7 more
- Distilled Water
- +5 more
-
Jeddah, Saudi ArabiaAlhamra TETAMMAN clinic (PHC)
Jul 18, 2022
Rhinoplasty Trial in Boston (Povidone-Iodine (PVP-I))
Withdrawn
- Rhinoplasty
- Povidone-Iodine (PVP-I)
-
Boston, MassachusettsBoston Medical Center
Feb 10, 2021
Acute Adenoviral Conjunctivitis Trial in United States (FST-100 Ophthalmic Suspension, Placebo)
Terminated
- Acute Adenoviral Conjunctivitis
- FST-100 Ophthalmic Suspension
- Placebo
-
Torrance, California
- +12 more
Aug 22, 2021
Dental Caries Trial in Kolonia (Test varnish, Standard varnish)
Completed
- Dental Caries
- Test varnish
- Standard varnish
-
Kolonia, Federated States of MicronesiaPohnpei State Hospital
Sep 9, 2020
SARS-CoV-2 Infection Trial in Germany (Convalescent/Vaccine-boosted Plasma (CP/PVP))
Recruiting
- SARS-CoV-2 Infection
- Convalescent/Vaccine-boosted Plasma (CP/PVP)
-
Berlin, Germany
- +15 more
Jan 21, 2022
Covid19 Trial in Vancouver (Povidone-iodine, Placebo)
Terminated
- Covid19
- Povidone-iodine
- Placebo
-
Vancouver, British Columbia, CanadaSt. Paul's Hospital
Jul 7, 2022
Prosthetic-joint Infection Trial (Surgiphor Irrigation Solution, Sterile saline)
Not yet recruiting
- Prosthetic-joint Infection
- Surgiphor Irrigation Solution
- Sterile saline
- (no location specified)
Jun 22, 2022
COVID19 Trial in Dhaka (Povidone-Iodine 0.4% NI, Povidone-Iodine 0.5% NI, Povidone-Iodine 0.6% NI)
Completed
- COVID19
- Povidone-Iodine 0.4% NI
- +6 more
-
Dhaka, BangladeshDhaka Medical College
Jan 10, 2022
Heart Failure, Edema, Volume Overload Trial in Istanbul, Kocaeli (Diuretic therapy)
Recruiting
- Heart Failure
- +3 more
- Diuretic therapy
-
Istanbul, Turkey
- +4 more
Jan 21, 2023
COVID-19, SARS-CoV 2 Trial in Lexington (Povidone-Iodine Nasal Spray and Gargle)
Recruiting
- COVID-19
- SARS-CoV 2
- Povidone-Iodine Nasal Spray and Gargle
-
Lexington, KentuckyUniversity of Kentucky
Jun 3, 2021
Bacterial Conjunctivitis Trial in Worldwide (SHP640, PVP-I 0.6%, Placebo)
Impacted Third Molar Tooth Trial (Control, 0.5% concentration of PVP-I, 1 % concentration of PVP-I)
Completed
- Impacted Third Molar Tooth
- Control
- +3 more
- (no location specified)
Mar 27, 2019
Oropharynx Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma Trial in Bordeaux, Nice (Mandibular Reconstruction (MR)
Recruiting
- Oropharynx Squamous Cell Carcinoma
- Oral Cavity Squamous Cell Carcinoma
- Mandibular Reconstruction (MR) with Preoperative Virtual Planning (PVP).
- Conventional Mandibular Reconstruction (MR without PVP)
-
Bordeaux, France
- +1 more
May 11, 2022
Glaucoma, Angle-Closure Trial in Guangzhou, Guangdong (phacoemulsification with intraocular lens implantation combined with
Active, not recruiting
- Glaucoma, Angle-Closure
- phacoemulsification with intraocular lens implantation combined with goniosynechialysis and goniotomy
- phacoemulsification with intraocular lens implantation combined with trabeculectomy
-
Guangzhou, Guangdong, China
- +1 more
Aug 1, 2022
Tooth Staining, Periodontitis Trial (Toothpaste with hexametaphosphate, tripolyphosphate and polyvinylpyrrolidone (PVP),
Not yet recruiting
- Tooth Staining
- Periodontitis
- Toothpaste with hexametaphosphate, tripolyphosphate and polyvinylpyrrolidone (PVP)
- Toothpaste without hexametaphosphate, tripolyphosphate and polyvinylpyrrolidone (PVP)
- (no location specified)
Apr 25, 2022
HIV (Human Immunodeficiency Virus) Trial in Bukoba, Geita (Enhanced Adherence Counseling and Conditional Cash Transfers)
Not yet recruiting
- HIV (Human Immunodeficiency Virus)
- Enhanced Adherence Counseling and Conditional Cash Transfers
-
Bukoba, Tanzania
- +1 more
Aug 10, 2022
Digestive System Disease Trial in Anaheim (PvP001 , PvP001 100 mg, PvP001 300 mg)
Completed
- Digestive System Disease
- PvP001 placebo
- +11 more
-
Anaheim, CaliforniaAnaheim Clinical Trials
Feb 4, 2022
Denosumab Allergy, Zoledronic Acid Allergy Trial in Shenzhen (Denosumab Injection, Zoledronate)
Completed
- Denosumab Allergy
- Zoledronic Acid Allergy
- Denosumab Injection
- Zoledronate
-
Shenzhen, Guangdong, ChinaShenzhenPH
Jan 15, 2023
Denosumab Allergy Trial in Shenzhen (Denosumab, Alendronate, Placebo)
Recruiting
- Denosumab Allergy
- Denosumab
- +2 more
-
Shenzhen, Guangdong, ChinaShenzhen People's Hospital
Dec 21, 2022